<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
/x/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: November 30, 2000
/ / TRANSITION REPORT PURSUANT TO SECTION 13(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to________
COMMISSION FILE NUMBER: 0-29346
FRMO CORP.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C>
DELAWARE 13-3754422
(State or other jurisdiction of incorporation (I.R.S.Employer Identification No.)
or organization)
271 NORTH AVENUE, NEW ROCHELLE, NY 10801
(Address of principal executive offices) (Zip Code)
</TABLE>
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (914) 636-3432
FRM NEXUS, INC.
(Former name, former address and former fiscal year,
if changed since last report)
__________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes (x) No( )
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS
Indicate by checkmark whether the registrant has filed all documents and reports
required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act
of 1934 subsequent to the distribution of securities under a plan confirmed by a
court. Yes ( ) No ( )
APPLICABLE ONLY TO CORPORATE ISSUERS: Indicate the number of shares outstanding
of each of the issuer's classes of common stock, at January 12, 2001: 1,800,000.
<PAGE> 2
FRMO CORP.
(FORMERLY FRM NEXUS, INC.)
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED NOVEMBER 30, 2000
<TABLE>
<CAPTION>
Page No.
--------
<S> <C>
PART I
Item 1. Financial Statements..................................... 2
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations............................... 8
Item 3. Quantitative and Qualitative Disclosures About
Market Risk....................................................... 23
PART II
Item 6. Exhibits and reports on form 8-K......................... 23
</TABLE>
1
<PAGE> 3
FRMO Corp. and Subsidiaries
(Formerly FRM Nexus, Inc.)
Index to Consolidated Financial Statements
PART I
ITEM 1. FINANCIAL STATEMENTS
<TABLE>
<S> <C>
Consolidated Balance Sheets -- November 30, 2000 (unaudited) and February 29, 2000........ 3
Consolidated Statements of Operations (unaudited) -- Nine months
and three months November 30, 2000 and 1999............................................ 5
Consolidated Statement of Stockholders' Equity (unaudited) --
Nine months ended November 30, 2000 ................................................... 6
Consolidated Statements of Cash Flows (unaudited) --
Nine months ended November 30, 2000 and 1999........................................... 7
Notes to Consolidated Financial Statements (unaudited).................................... 8
</TABLE>
2
<PAGE> 4
FRMO Corp.and Subsidiaries
(Formerly FRM Nexus, Inc.)
Consolidated Balance Sheets
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
(UNAUDITED)
<S> <C> <C>
ASSETS
Current assets:
Cash & cash equivalents $ 585,233 $ 591,408
Mortgage and notes receivable - current 28,448 26,597
Finance receivables, net 4,345,860 2,479,999
Other current assets 97,379 103,994
---------- ----------
Total current assets 5,056,920 3,201,998
---------- ----------
Property and equipment:
Property and equipment, at cost 537,428 348,575
Less accumulated depreciation and amortization 180,872 115,794
---------- ----------
356,556 232,781
---------- ----------
Other assets:
Real estate held for development and sale 498,548 510,880
Mortgage and notes receivable 3,131,110 3,152,683
Accrued interest receivable - related party mortgage 321,150 321,150
Loans receivable 136,609 98,381
Other 61,544 95,991
Net assets of discontinued operations -- 1,174,892
---------- ----------
Total other assets 4,148,961 5,353,977
---------- ----------
Total assets $9,562,437 $8,788,756
========== ==========
</TABLE>
See notes to interim consolidated financial statements.
3
<PAGE> 5
FRMO Corp. and Subsidiaries
(Formerly FRM Nexus, Inc.)
Consolidated Balance Sheets (continued)
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
(UNAUDITED)
<S> <C> <C>
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses $ 308,022 $ 213,683
Current portion of notes payable 58,254 19,282
Due to finance customers 2,104,345 1,402,546
Income taxes payable 11,360 5,367
Other current liabilities 34,258 20,000
----------- -----------
Total current liabilities 2,516,239 1,660,878
----------- -----------
Other liabilities:
Notes payable, including $306,500
payable to related party at November 30, 2000 378,299 24,655
Deferred income 2,407,311 2,407,311
----------- -----------
Total other liabilities 2,785,610 2,431,966
----------- -----------
Minority interest in subsidiary 100,612 --
----------- -----------
Commitments and contingencies
Stockholders' equity:
Common stock - $.10 par value;
Authorized - 2,000,000 shares;
Issued and outstanding - 1,800,000 shares at November 30, 2000
and 1,816,462 shares at February 29, 2000 180,000 181,646
Capital in excess of par value 5,800,220 5,826,909
Accumulated deficit (1,820,244) (1,312,643)
----------- -----------
Total stockholders' equity 4,159,976 4,695,912
----------- -----------
Total liabilities and stockholders' equity $ 9,562,437 $ 8,788,756
=========== ===========
</TABLE>
See notes to interim consolidated financial statements.
4
<PAGE> 6
FRMO Corp. and Subsidiaries
(Formerly FRM Nexus, Inc.)
Consolidated Statements of Operations
(unaudited)
<TABLE>
<CAPTION>
THREE MONTHS ENDED NINE MONTHS ENDED
NOVEMBER 30, NOVEMBER 30,
2000 1999 2000 1999
---- ---- ---- ----
<S> <C> <C> <C> <C>
REVENUES
Sale of real estate $ -- $ 85,000 $ 69,000 $ 296,000
Rental income 23,409 33,154 70,229 85,339
Interest from mortgages 22,832 58,062 68,942 174,592
Income from the purchase
and collections of medical receivables 301,735 197,932 745,114 807,513
Medical management service fees 239,879 -- 659,829 --
----------- ----------- ----------- -----------
Total income 587,855 374,148 1,613,114 1,363,444
----------- ----------- ----------- -----------
COSTS AND EXPENSES
Real estate 77,505 153,857 305,718 518,292
Medical receivables 323,485 357,586 1,063,211 988,402
Medical management services 228,078 -- 739,013 --
Corporate expenses 127,382 146,716 331,409 335,660
Depreciation and amortization 22,176 15,774 65,076 44,029
----------- ----------- ----------- -----------
Total costs and expenses 778,626 673,933 2,504,427 1,886,383
----------- ----------- ----------- -----------
Loss from operations (190,771) (299,785) (891,313) (522,939)
----------- ----------- ----------- -----------
Other income (expense):
Interest income 8,173 4,933 19,858 7,327
Interest expense (5,558) (6,183) (19,432) (37,895)
Minority interest in net income of subsidiary (612) -- (612) --
----------- ----------- ----------- -----------
2,003 (1,250) (186) (30,568)
----------- ----------- ----------- -----------
Loss from continuing operations before
provision for income taxes (188,768) (301,035) (891,499) (553,507)
Provision for income taxes 4,928 4,925 15,130 15,223
----------- ----------- ----------- -----------
Loss from continuing operations (193,696) (305,960) (906,629) (568,730)
Income from discontinued operations, net of taxes
(including gain on sale of subsidiary of $-0- for the three months
ended November 30, 2000 and 1999, $381,182 and $96,303 for
the nine months ended November 30, 2000 and 1999, respectively) -- 60,920 399,028 353,443
----------- ----------- ----------- -----------
Net Loss $ (193,696) $ (245,040) $ (507,601) $ (215,287)
=========== =========== =========== ===========
Basic and diluted loss per common share:
Loss from continuing operations $ (0.11) $ (0.17) $ (0.50) $ (0.31)
Income from discontinued operations -- 0.03 0.22 0.19
----------- ----------- ----------- -----------
Basic and diluted loss per common share $ (0.11) $ (0.14) $ (0.28) $ (0.12)
=========== =========== =========== ===========
Number of shares used in computation of basic and
diluted earnings per share 1,800,000 1,816,462 1,809,638 1,816,462
=========== =========== =========== ===========
</TABLE>
See notes to interim consolidated financial statements.
5
<PAGE> 7
FRMO Corp. and Subsidiaries
(Formerly FRM Nexus, Inc.)
Consolidated Statement of Stockholders' Equity
February 29, 2000 through November 30, 2000
(unaudited)
<TABLE>
<CAPTION>
COMMON STOCK ADDITIONAL TOTAL
--------------------- PAID-IN (ACCUMULATED STOCKHOLDERS' COMPREHENSIVE
SHARES AMOUNT CAPITAL DEFICIT) EQUITY (LOSS) INCOME
------ ------ ----------- -------- ------ ------------
<S> <C> <C> <C> <C> <C> <C>
BALANCE, FEBRUARY 29, 2000 1,816,462 $ 181,646 $ 5,826,909 $(1,312,643) $ 4,695,912
PURCHASE AND RETIREMENT OF
TREASURY STOCK (16,462) (1,646) (26,689) -- (28,335)
NET LOSS -- -- -- (507,601) (507,601) $(507,601)
---------
COMPREHENSIVE LOSS $(507,601)
--------- --------- ----------- ----------- ----------- =========
BALANCE, NOVEMBER 30, 2000 1,800,000 $ 180,000 $ 5,800,220 $(1,820,244) $ 4,159,976
========= ========= =========== =========== ===========
</TABLE>
See notes to interim consolidated financial statements.
6
<PAGE> 8
FRMO Corp. and Subsidiaries
(Formerly FRM Nexus, Inc.)
Consolidated Statements of Cash Flows
(Unaudited)
<TABLE>
<CAPTION>
NINE MONTHS ENDED
NOVEMBER 30,
2000 1999
---- ----
<S> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $ (507,601) $ (215,287)
Adjustments to reconcile net loss to net
cash used in operating activities:
Depreciation and amortization 65,076 44,029
Gain on sale of real estate held for development and sale (15,727) (7,903)
Gain on sale of subsidiaries (381,182) (96,303)
Provision for bad debts 207,590 21,994
Minority interest in net income of subsidiary 612 --
Changes in operating assets and liabilities:
Collections from the sale of real estate held for
development and sale, net of payment to participant 69,000 280,634
Additions to real estate held for development and sale (40,941) --
Prepaid expenses, miscellaneous receivables and other assets 41,062 (107,554)
Net assets of discontinued operations (18,926) (74,335)
Accounts payable, accrued expenses and taxes 100,332 (68,824)
Other current liabilities 14,258 (45,139)
----------- -----------
Net cash used in operating activities (466,447) (268,688)
----------- -----------
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures & intangible assets (71,161) (85,068)
Finance receivables (2,073,451) 418,598
Due to finance customers 701,799 45,294
Principal payments on notes receivable 19,722 18,032
Loan receivable (79,685) --
Principal payments on loan receivable 41,456 --
Proceeds from sale of subsidiaries 1,575,000 975,000
----------- -----------
Net cash provided by investing activities 113,680 1,371,856
----------- -----------
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds of notes payable 726,500 96,779
Principal payments on notes payable (451,573) (950,938)
Sale of equity by affiliate 100,000
Purchase and retirement of treasury stock (28,335) --
----------- -----------
Net cash provided by (used in) financing activities 346,592 (854,159)
----------- -----------
Net (decrease) increase in cash and cash equivalents $ (6,175) $ 249,009
Cash and cash equivalents, beginning of period 591,408 253,012
----------- -----------
Cash and cash equivalents, end of period $ 585,233 $ 502,021
=========== ===========
ADDITIONAL CASH FLOW INFORMATION
Interest paid $ 22,192 $ 41,498
=========== ===========
Income taxes paid $ 17,916 $ 11,701
=========== ===========
NONCASH INVESTING AND FINANCING ACTIVITIES
Assets acquired under capital leases $ 117,689 $ --
=========== ===========
</TABLE>
See notes to interim consolidated financial statements
7
<PAGE> 9
FRMO CORP. AND SUBSIDIARIES
(FORMERLY FRM NEXUS, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared
in accordance with accounting principles generally accepted in the United States
for interim financial information in response to the requirements of Article 10
of Regulation S-X. Accordingly they do not include all of the information and
footnotes required by accounting principles generally accepted in the United
States for complete financial statements. In the opinion of management, the
accompanying unaudited consolidated financial statements contain all adjustments
(consisting only of normal recurring items) necessary to present fairly the
financial position as of November 30, 2000; results of operations for the nine
months and three months ended November 30, 2000 and 1999; cash flows for the
nine months ended November 30, 2000 and 1999; and changes in stockholders'
equity for the nine months ended November 30, 2000. For further information,
refer to the Company's financial statements and notes thereto included in the
Company's Form 10-K for the year ended February 29, 2000. The consolidated
balance sheet at February 29, 2000 was derived from the audited financial
statements as of that date. Results of operations for interim periods are not
necessarily indicative of annual results of operations.
Certain prior year amounts were reclassified to conform with the current year
presentation.
2. ORGANIZATION OF THE COMPANY
On August 9, 2000, one of the Companies subsidiaries, PSI Food Services, Inc.
amended its certificate of incorporation, changing its name to MFC Development
Corp. ("MFC"). On August 31, 2000, the Company transferred to MFC all of its
assets (except for $10,000), including ownership of all of its wholly owned
subsidiaries and all of its liabilities. On August 31, 2000, FRMO filed Form 8-K
with the Securities and Exchange Commission, which disclosed that FRMO
contemplates on or about November 30, 2000, or such later date as the
registration of the common stock of MFC Development Corp. shall have become
effective, distributing to its shareholders on the record date one share of MFC
common stock for each one share of FRMO's outstanding common stock at the close
of business on November 1, 2000 (the record date). There are presently 1,800,000
shares of common stock of FRMO outstanding. On October 19, 2000 FRMO filed Form
8-K with the Securities and Exchange Commission, which disclosed the board of
directors' approval of the distribution. MFC filed a Form 10 on October 2, 2000
to register its common stock. Amendment Nos. 1 and 2 to Form 10 were filed on
November 20, 2000 and December 6, 2000. The Company is currently waiting for any
further comment from the Securities and Exchange Commission.
In addition to the two operating divisions of the Company, real estate and
medical, a new division, Capco was formed during the quarter ended November 30,
2000. Operation of the Capco division commenced on September 14, 2000, when the
Articles of
8
<PAGE> 10
FRMO CORP. AND SUBSIDIARIES
(FORMERLY FRM NEXUS, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
2. ORGANIZATION OF THE COMPANY (CONTINUED)
Organization in New York State for FRM N.Y. Capital LLC, an 80% majority owned
subsidiary of PSI Capital Corp., a wholly owned subsidiary of the Company, were
filed. This LLC was formed for the purpose of being approved as a "certified
capital company" pursuant to Sections 11 and 1511 of the New York State Tax Law
(herein a "Capco") under the Capco Program Three. A "certified capital company"
as used in this context is a "for profit" entity, such as a limited liability
company, located and qualified to conduct business in New York State which is
certified by the New York State Insurance Department ("Department") based on
standards set forth in the New York Tax Law (the "Statute"). The Capco was
approved on November 28, 2000 and certified to participate in New York's Capco
Program Three. The Statute creates a tax credit incentive mechanism to increase
investment of financial resources of insurance companies into providing venture
capital to businesses approved by the Department as qualified to provide jobs
and promote the growth of the economy in New York State ("Qualified
Businesses").
On November 29, 2000, the Company amended its certificate of incorporation and
changed its name from FRM Nexus, Inc. to FRMO Corp.
3. FINANCE RECEIVABLES, NET
Net finance receivables consist of the following:
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
<S> <C> <C>
Gross finance receivables $5,213,989 $2,958,825
Allowance for credit losses (420,078) (212,488)
Deferred finance income (448,051) (266,338)
---------- ----------
$4,345,860 $2,479,999
========== ==========
</TABLE>
These receivables are collateral for a line of credit (see note 5).
The Company purchases the receivables and has the right to return the "invalid
receivables". By contractual definition these are receivables that have not been
recovered from insurance companies because of denials, requests for additional
information not readily available, or a matter under investigation within 180
days of the purchase date. For receivables purchased in the years ended
February 29, 2000 and February 28, 1999 and the three months ended May 31, 2000
(unaudited) the Company returned approximately 21%, 17% and 19%, respectively.
The Company does not expect the trend of returned receivables to change in the
future.
In addition to the right to return the invalid receivables to the Seller, the
Company has the right to offset any of its obligations to the Seller by any
invalid receivables. As a result of the right of return and right of offset
features, the Company believes that a valuation allowance generally is not
required for these receivables.
9
<PAGE> 11
FRMO CORP. AND SUBSIDIARIES
(FORMERLY FRM NEXUS, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
4. PROPERTY AND EQUIPMENT
Property and equipment consists of the following:
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
<S> <C> <C>
Leasehold improvements $ 52,902 $ 51,402
Computer equipment 222,993 173,414
Medical equipment 46,350 32,500
Equipment under capital leases 185,060 67,371
Other equipment and furniture 30,123 23,888
-------- --------
537,428 348,575
Less accumulated depreciation and amortization 180,872 115,794
-------- --------
Property and equipment, net $356,556 $232,781
======== ========
</TABLE>
As of November 30, 2000 and February 29, 2000, accumulated amortization of
equipment under capital leases was $40,617 and $21,699.
Depreciation expense for the nine months ended November 30, 2000 and 1999, which
includes amortization under capital leases was $65,076 and $44,029.
5. NOTES PAYABLE
Notes payable include the following:
<TABLE>
<CAPTION>
NOVEMBER 30, FEBRUARY 29,
2000 2000
---- ----
<S> <C> <C>
Related party credit line $306,500 $ --
Related party escrow loan -- --
Capital lease obligations 130,053 43,937
-------- -------
436,553 43,937
Less current maturities 58,254 19,282
-------- -------
Long-term debt $378,299 $24,655
======== =======
</TABLE>
Related Party Credit Lines: In December 1997, a $700,000 line of credit was
obtained from a related party, Northwest Management Corp. ("NMC"), a shareholder
of the Company. In January 1999, the line of credit was increased to $785,000.
The president of NMC, who is also a shareholder of the Company, has the power to
vote NMC shares, which are owned by his two children. The line was terminated by
mutual consent of both parties upon full repayment on June 21, 2000 of the
outstanding balance of $200,000. Interest was calculated at a rate of 12% per
annum.
10
<PAGE> 12
FRMO CORP. AND SUBSIDIARIES
(FORMERLY FRM NEXUS, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
5. NOTES PAYABLE (CONTINUED)
In October 2000, a $500,000 line of credit was obtained from a related party,
NWM Capital, LLC. ("NWM"), which is owned by a shareholder of the Company. In
December 2000, the line of credit was increased to $658,000. The line, under
which there was an outstanding balance of $306,500 at November 30, 2000, expires
on October 31, 2002. Interest is calculated at a rate of 15% per annum. Monthly
interest only payments are due through October 31, 2002. Commencing on December
1, 2002, monthly payments will be $34,000 per month plus interest, with a final
payment of any outstanding balance at October 31, 2003, the maturity date. The
credit line may only be prepaid on six months prior written notice. The Company,
at the option of the lender, may be required to prepay up to an aggregate of 20%
of the stated principal amount of the credit line on 30 days prior written
notice. There were no commitment fees paid in connection with this line of
credit.
The line has a joint and several obligation of the Company and its subsidiary,
Medical Financial Corp. The line is collateralized by the second mortgage
receivable in Granby, Connecticut and certain purchased insurance claims
receivable of Medical Financial Corp., which are not older than six months (see
Note 3) equal to at least 222% of the principal sum outstanding under the line.
Related party escrow loan: In February 1999, a related partnership, whose
partners are directors, officers and shareholders of the Company, committed to
place in an escrow account until March 15, 2001 an investment portfolio, which
at the time was valued at $240,000, for the benefit of the Medical Financial
Corp. subsidiary. This investment portfolio was held in escrow and used as
collateral for the purpose of obtaining margin loans. All risks and rewards of
the investment portfolio pass to the related party. The Company, being the
primary obligor on the margin loans, is responsible for the repayment of the
loans. The margin loans bear interest at a variable rate based on market
condition set at the discretion of the investment brokerage firm. A fee is
payable monthly to the related party at the rate of 5% per annum on the value of
the investment escrow account. This fee is included in interest expense.
Proceeds from the loan may only be used to fund the purchase of certain medical
receivables. The loan is repaid as payment is received from such receivables. On
June 26, 2000, the then outstanding balance of $170,000 was paid in full. On
June 30, 2000, the line was terminated by mutual consent of both parties.
Interest expense on these related party borrowings was $10,358 and $33,738 for
the nine months ended November 30, 2000 and 1999.
Capital Lease Obligations: The Company has acquired certain equipment under
various capital leases expiring in 2004. The leases provide for monthly payments
of principal and interest of $5,782 and have been capitalized at imputed
interest rates of 10.00% to 16.72%.
11
<PAGE> 13
FRMO CORP. AND SUBSIDIARIES
(FORMERLY FRM NEXUS, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
5. NOTES PAYABLE (CONTINUED)
Aggregate maturities of the amount of notes payable and capital leases for the
years ending February 28 are as follows:
<TABLE>
<CAPTION>
NOTES CAPITAL LEASE
PAYABLE OBLIGATIONS TOTAL
------- ------------- -----
<S> <C> <C> <C>
2001 (three months) $ -- $ 17,347 $ 17,347
2002 -- 66,625 66,625
2003 306,500 51,624 358,124
2004 -- 11,393 11,393
-------- -------- --------
306,500 146,989 453,489
Amount representing interest -- 16,936 16,936
-------- -------- --------
Total (a) $306,500 $130,053 $436,553
======== ======== ========
</TABLE>
(a) -- Total capital lease obligations represent present value of minimum lease
payments.
6. MINIMUM OPERATING LEASE COMMITMENTS
Subject to annual real estate adjustments, the following is a schedule of future
minimum rental payments required under the Company's operating leases for the
years ending February 28:
<TABLE>
<S> <C>
2001 (three months) $ 42,100
2002 139,600
2003 130,920
2004 133,556
2005 138,744
Thereafter 160,800
--------
Total $745,720
========
</TABLE>
12
<PAGE> 14
FRMO CORP. AND SUBSIDIARIES
(FORMERLY FRM NEXUS, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
7. INCOME TAXES
The provision for income taxes consist of the following:
<TABLE>
<CAPTION>
THREE MONTHS ENDED NINE MONTHS ENDED
NOVEMBER 30, NOVEMBER 30,
2000 1999 2000 1999
---- ---- ---- ----
<S> <C> <C> <C> <C>
Current:
Federal $ -- $ -- $ -- $ --
State 4,928 4,925 15,130 15,223
------ ------ ------- -------
Total current 4,928 4,925 15,130 15,223
------ ------ ------- -------
Deferred:
Federal -- -- -- --
State -- -- -- --
------ ------ ------- -------
Total deferred -- -- -- --
------ ------ ------- -------
Total $4,928 $4,925 $15,130 $15,223
====== ====== ======= =======
</TABLE>
8. DISCONTINUED OPERATIONS
On May 14, 1999 the Company sold Wendclark, Inc., one of the two subsidiaries
that operated in the food service division. The Company received $975,000 in
cash, resulting in a gain of $96,303, which was recorded during the three months
ended May 31, 1999. As a result of this sale, $2,342,555 of debt that was
carried by Wendclark was assumed by the buyer. On May 23, 2000 the Company
committed to sell Wendcello Corp., the remaining subsidiary that operated in the
food service division. On June 20, 2000 the Company completed the sale of
Wendcello Corp., including all of its assets and liabilities, and received
$1,575,000 in cash, resulting in a gain of approximately $381,000 that was
recorded during the six months ended August 31, 2000. As a result of this sale,
$125,000 of current debt that was carried on Wendcello was eliminated. During
the period from May 23, 2000 (the measurement date for discontinuing operations
of the food service division) to June 20, 2000 (disposal date), net income from
operations of the discontinued food service division was $11,700. The results of
operations of both subsidiaries have been classified as discontinued operations
and prior periods have been restated.
13
<PAGE> 15
FRMO CORP. AND SUBSIDIARIES
(FORMERLY FRM NEXUS, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
8. DISCONTINUED OPERATIONS (CONTINUED)
The net assets of the discontinued operations are as follows:
<TABLE>
<CAPTION>
NOVEMBER 30 FEBRUARY 29
2000 2000
---- ----
<S> <C> <C>
Cash & cash equivalents $ -- $ 328,607
Inventories -- 62,360
Other current assets -- 146,552
Property and equipment, at cost -- 2,352,846
Less accumulated depreciation and amortization -- (1,548,005)
Other assets -- 536,579
---- -----------
Total assets -- 1,878,939
---- -----------
Accounts payable and accrued expenses -- 554,397
Other current liabilities -- 149,650
---- -----------
Total liabilities -- 704,047
---- -----------
Net assets of discontinued operations $ -- $ 1,174,892
==== ===========
</TABLE>
A summary of the results of discontinued operations for the food services
division is as follows for the nine months and three months ended:
<TABLE>
<CAPTION>
THREE MONTHS ENDED NINE MONTHS ENDED
NOVEMBER 30 NOVEMBER 30
2000 1999 2000 1999
---- ---- ---- ----
<S> <C> <C> <C> <C>
Operating revenues, including
gain on sale of subsidiary of $-0-
for three months ended November
30, 2000 and 1999, $381,182 for
the nine months ended November 30,
2000 and $96,303 for the nine
months ended November
30, 1999 $ -- $ 2,702,854 $ 3,714,425 $9,596,003
Operating expenses -- 2,644,474 3,316,091 9,201,153
------- ----------- ----------- ----------
Income from operations -- 58,380 398,334 394,850
Interest expense, net of
interest (income) -- (1,290) (1,774) 41,407
------- ----------- ----------- ----------
Income before income taxes -- 59,670 400,108 353,443
Income taxes -- (1,250) 1,080 --
------- ----------- ----------- ----------
Income from discontinued
operations, net of taxes $ -- $ 60,920 $ 399,028 $ 353,443
======= =========== =========== ==========
</TABLE>
9. MINORITY INTEREST
Minority interest in subsidiary represents the remaining 20% ownership of the
Class A members of FRM NY Capital, LLC, the subsidiary that operates in the
Capco division.
14
<PAGE> 16
FRMO CORP. AND SUBSIDIARIES
(FORMERLY FRM NEXUS, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
10. BUSINESS SEGMENT INFORMATION
Operating segments are managed separately and represent separate business units
that offer different products and serve different markets. The Company's
reportable segments include: (1) real estate, (2) medical (3) capco and (4)
other, which is comprised of corporate overhead and net assets of discontinued
operations. The real estate segment operates in New York and Connecticut. The
medical segment operates in New York and New Jersey. The capco segment was
formed on September 14, 2000 and operates only in New York.
Upon the certification of Capco by New York State on November 28, 2000, an
insurance company can purchase up to $10 million of debt of Capco and receive a
dollar-for-dollar tax credit spread out over a 10 year period beginning in 2002.
Such an investing insurance company is called a "Certified Investor" and Capco
will seek one or more such investors for $10 million. Capco Program Three
authorizes state tax credits of up to $150 million for all insurance company
participants. Capco will use (i) its own capital of $500,000, 80% of which was
supplied by the Company and 20% by Daniel Elstein who was a director of FRM
Corp. in 1997-1998, plus (ii) the investment of the Certified Investor to take
substantial equity interests in New York companies in order to encourage and
assist them in creating, developing and expanding their business. Capco's
emphasis will be on viable small business enterprises which have had difficulty
in attracting institutional venture capital and which will expand employment
opportunities in New York, thereby promoting the growth of the State's economy.
By virtue of the equity interests, Capco obtains in the Qualified Businesses, or
through contemporaneous agreements, it is expected that it will be a significant
factor in the direction and control of the Qualified Businesses in which it
invests its funds. Capco's mission is to be an active participant with the
management of its selected companies, in order to grow the values of the
qualified company, its own investment therein and the interest of the Certified
Investor at the same time that the enterprise contributes to more jobs and
growth in New York State. As of November 30, 2000, Capco had not yet commenced
operations.
The accounting policies of the segments are the same as those described in the
summary of significant accounting policies included in the Company's Form 10-K
for the year ended February 29, 2000. All inter-segment balances have been
eliminated. Inter-segment balances that have not been capitalized, bear interest
at the rate of 10% per annum and are included in net interest expense. Business
segment information for the nine months and three months ended November 30, 2000
and 1999 follows. Certain prior year information has been reclassified to
conform with the current year presentation.
15
<PAGE> 17
FRMO CORP. AND SUBSIDIARIES
(FORMERLY FRM NEXUS, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
10. BUSINESS SEGMENT INFORMATION (CONTINUED)
<TABLE>
<CAPTION>
REAL
ESTATE MEDICAL CAPCO OTHER TOTAL
------ ------- ----- ----- -----
<S> <C> <C> <C> <C> <C>
THREE MONTHS ENDED NOVEMBER 30, 2000
Total revenue from external customers $ 46,241 $ 541,614 $ -- $ -- $ 587,855
Loss from operations (32,193) (30,259) -- (128,319) (190,771)
Interest income (expense), net 8,500 (9,038) 3,153 -- 2,615
Minority interest -- -- (612) -- (612)
(Loss) income from continuing operations
before provision for income taxes (23,693) (39,297) 2,541 (128,319) (188,768)
Capital expenditures 4,322 5,818 -- -- 10,140
Depreciation and amortization 929 20,310 -- 937 22,176
THREE MONTHS ENDED NOVEMBER 30, 1999
Total revenue from external customers $ 176,216 $ 197,932 $ -- $ -- $ 374,148
Income (loss) from operations 19,909 (172,978) -- (146,716) (299,785)
Interest income (expense), net 51,036 (52,286) -- -- (1,250)
Minority interest -- -- -- -- --
Income (loss) from continuing operations
before provision for income taxes 70,945 (225,264) -- (146,716) (301,035)
Capital expenditures 4,185 12,229 -- 1,248 17,662
Depreciation and amortization 2,450 13,324 -- -- 15,774
NINE MONTHS ENDED NOVEMBER 30, 2000
Total revenue from external customers $ 208,171 $ 1,404,943 $ -- $ -- $ 1,613,114
(Loss) from operations (99,690) (457,402) -- (334,221) (891,313)
Interest income (expense), net 30,782 (33,509) 3,153 -- 426
Minority interest -- -- (612) -- (612)
(Loss) income from continuing operations
before provision for income taxes (68,908) (490,911) 2,541 (334,221) (891,499)
Assets - continuing 4,037,767 5,004,045 503,072 17,553 9,562,437
Assets - discontinued -- -- -- -- --
Total assets 4,037,767 5,004,045 503,072 17,553 9,562,437
Capital expenditures 4,322 184,028 -- 500 188,850
Depreciation and amortization 2,143 60,121 -- 2,812 65,076
NINE MONTHS ENDED NOVEMBER 30, 1999
Total revenue from external customers $ 555,931 $ 807,513 $ -- $ -- $ 1,363,444
Income (loss) from operations 31,968 (219,247) -- (335,660) (522,939)
Interest income (expense), net 129,454 (160,022) -- -- (30,568)
Minority interest -- -- -- -- --
Income (loss) from continuing operations
before provision for income taxes 161,422 (379,269) -- (335,660) (553,507)
Assets - continuing 5,108,194 3,019,441 -- 21,262 8,148,897
Assets - discontinued -- -- -- 1,875,872 1,875,872
Total assets 5,108,194 3,019,441 -- 1,897,134 10,024,769
Capital expenditures 4,185 79,635 -- 1,248 85,068
Depreciation and amortization 5,671 38,358 -- -- 44,029
</TABLE>
16
<PAGE> 18
FRMO CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
<TABLE>
<S> <C> <C> <C> <C>
Aug 31:
2000
Total revenue from external customers 161,930 863,329 -- 1,025,259
(Loss) income from operations (67,497) (427,143) (205,902) (700,542)
Interest expense, net 22,282 (24,471) -- (2,189)
(Loss) income from continuing operations
before provision for income taxes (45,215) (451,614) (205,902) (702,731)
Assets - continuing 4,618,228 4,447,413 18,491 9,084,132
Assets - discontinued -- -- -- --
Total assets 4,618,228 4,447,413 18,491 9,084,132
Capital expenditures -- 178,210 500 178,710
Depreciation and amortization 1,214 39,811 1,875 42,900
1999
Total revenue from external customers 379,715 609,581 -- 989,296
Income (loss) from operations 12,059 (46,269) (188,944) (223,154)
Interest expense, net 78,418 (107,736) -- (29,318)
(Loss) income from continuing operations
before provision for income taxes 90,477 (154,005) (188,944) (252,472)
Assets - continuing 5,068,430 2,969,225 3,169 8,040,824
Assets - discontinued -- -- 1,356,466 1,356,466
Total assets 5,068,430 2,969,225 1,359,635 9,397,290
Capital expenditures -- 67,406 -- 67,406
Depreciation and amortization 3,221 25,034 -- 28,255
</TABLE>
17
<PAGE> 19
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND
FINANCIAL CONDITION
All statements contained herein that are not historical facts, including but not
limited to, statements regarding future operations, financial condition and
liquidity, expenditures to develop real estate owned by the Company, future
borrowing, capital requirements and the Company's future development plans are
based on current expectations. These statements are forward looking in nature
and involve a number of risks and uncertainties. Actual results may differ
materially. Among the factors that could cause actual results to differ
materially are the following: changes in the business of the Company's medical
provider clients, changes in the real estate and financial markets and other
risk factors described herein and in the Company's reports filed and to be filed
from time to time with the Commission. The discussion and analysis below is
based on the Company's unaudited consolidated financial statements for the nine
months and three months ended November 30, 2000 and 1999. The following should
be read in conjunction with the Management's Discussion and Analysis of results
of operations and financial condition included in the 2000 10-K.
OVERVIEW
FRMO generates revenues from two business segments: real estate and medical. A
third segment, Capco, was formed during the three months ended November 30, 2000
and was not yet operational. The real estate segment consists of various parcels
of real estate, held for future development and sale, in which co-investors also
have interests, and mortgage notes receivable on two properties that were
previously sold. The medical segment consists of three Limited Liability
Companies which act as service organizations for providers of medical services
and a wholly-owned subsidiary, Medical Financial Corp., which purchases medical
insurance claims receivable, paying cash to the medical provider in return for a
negotiated fee. The Capco segment consists of an 80% ownership in FRM NY
Capital, LLC, a certified capital company as described in Note 2 and Note 10 of
the consolidated financial statements.
Revenues in the real estate division vary substantially from period to period
depending on when a particular transaction closes and depending on whether the
closed transaction is recognized for accounting purposes as a sale or reflected
as a financing or is deferred to a future period. On May 23, 2000 the Company
committed to sell Wendcello Corp., the remaining subsidiary that operated in the
food service division. On June 20, 2000 the Company completed the sale and
received $1,575,000 in cash, resulting in a gain of approximately $381,000 that
was recorded during the six months ended August 31, 2000. As a result of that
sale and the sale of the Wendclark subsidiary in May 1999, the food service
segment has been classified as discontinued operations and prior periods have
been restated.
On August 9, 2000, one of the Companies subsidiaries, PSI Food Services, Inc.
amended its certificate of incorporation, changing its name to MFC Development
Corp. ("MFC"). On August 31, 2000, the Company transferred to MFC all of its
assets (except for $10,000), including ownership of all of its wholly owned
subsidiaries and all of its liabilities. On August 31, 2000, FRMO filed Form 8-K
with the Securities and Exchange Commission, which disclosed that FRMO
contemplates on or about November 30, 2000,
18
<PAGE> 20
or such later date as the registration of the common stock of MFC Development
Corp. shall have become effective, distributing to its shareholders on the
record date one share of MFC common stock for each one share of FRMO's
outstanding common stock at the close of business on November 1, 2000 (the
record date). There are presently 1,800,000 shares of common stock of FRMO
outstanding. MFC filed a Form 10 on October 2, 2000 to register its common
stock. Amendment Nos. 1 and 2 to Form 10 were filed on November 20, 2000 and
December 6, 2000. The Company is currently waiting for any further comment from
the Securities and Exchange Commission.
RESULTS OF OPERATIONS
2000 PERIOD COMPARED TO THE 1999 PERIOD
The Company's revenues from continuing operations increased by $214,000 or 57%,
for the three months ended November 30, 2000 ("2000") to $588,000 from $374,000
for the three months ended November 30, 1999 ("1999"). The Company's revenues
from continuing operations increased by $250,000 or 18%, for the nine months
ended November 30, 2000 ("2000") to $1,613,000 from $1,363,000 for the nine
months ended November 30, 1999 ("1999"). The increase in both the nine month and
three month periods was a result of an increase in the medical division, offset
by decreased revenues in the real estate division.
Revenue in the real estate division decreased in 2000 by $130,000, to $46,000
for the three month period and decreased by $348,000 to $208,000 for the nine
month period. The decrease in revenue in both the three month and nine month
periods were due to decreases of $85,000 and $227,000 in the sales of real
estate in the three month and nine month periods ended in 2000 as compared to
1999. Rental income decreased by $10,000 and $15,000 in the three months and
nine months ended in 2000 because rent is no longer being received on the
properties that were sold during the remainder of fiscal 2000. The $35,000 and
$106,000 decrease in the three months and nine months ended in 2000 in interest
from mortgages was attributable to a decrease in accrued interest income on the
mortgage receivable from the property located in Goshen, NY. Interest is no
longer being accrued on this mortgage because the annual interest payment that
was due in February 2000 has not been paid.
The $344,000 increase in revenues in the medical division for the three month
period ended in 2000 was due to an increase in both earned fees from the
purchase and collection of medical claims and management fees. The $597,000 net
increase in revenue in the medical division for the nine month period ended in
2000 was due to an increase in management fees, offset by a decrease of fees
from the purchase and collection of medical claims.
The increase in management fees of $240,000 and $660,000 for the three months
and nine months ended in 2000, was a result of the ownership, beginning in
February 2000, of an MRI facility that provides management services to a finance
client's radiology practice. Management fees were also generated, beginning in
April 2000, from the management of a finance client's physical therapy practice.
Two other finance client's practices were managed for a temporary period in
2000. These fees are net of reserves of $70,000 and $190,000 for the three
months and nine months ended November 30, 2000.
19
<PAGE> 21
The increase in earned fees from the purchase and collection of medical claims
of $104,000 for the three month period was due to an increase in medical claims
purchased in current and earlier periods, which resulted in an increase in
revenue recognition over the period of collections, which is usually six months.
The increase in claims purchased was due to the Company obtaining new clients
and additional purchases from existing clients. The increase in purchases during
the three months ended in 2000 resulted in an overall increase in purchases of
$1,653,000 during the nine month period ended in 2000 as compared to the same
nine month period ended in 1999. The income that is derived from these purchases
is deferred and recognized as the claims are collected during an average six
month period. The decrease in earned fees of $63,000 for the nine month period
was due to a decrease in medical claims purchased in earlier periods, which
resulted in a decrease in revenue recognition over the period of collections,
which is usually six months. The decrease in claims purchased in earlier periods
was due to the Company's decision to be more selective in the bill purchasing
process. Since the Company has become more selective in determining which bills
to purchase, the collection process is more efficient, since the insurance
companies are less likely to delay or question certain procedures. This reduces
the cost and time of the Company's collection effort for each bill and results
in a more rapid collection of the receivable.
Costs and expenses from continuing operations increased by $105,000, or 16%, for
the three months ended in 2000, to $779,000 as compared to $674,000 for the same
period ended in 1999. Costs and expenses from continuing operations increased by
$618,000, or 33%, for the nine months ended in 2000, to $2,504,000 as compared
to $1,886,000 for the same period ended in 1999. The net increase for the three
months ended in 2000 was due to increases of $194,000 in the medical division
and $6,000 in depreciation and amortization, which were offset by decreases of
$76,000 in the real estate division and $19,000 in corporate expenses. The net
increase for the nine months ended in 2000 was due to increases of $814,000 in
the medical division and $21,000 in depreciation and amortization, which were
offset by decreases of $213,000 in the real estate division and $4,000 in
corporate expenses.
The decrease in costs and expenses in the real estate division in both the three
month and nine month periods ended in 2000 were due to a decrease in the amount
of properties sold in 2000, which results in a decrease in the cost of sales.
Operating expenses also decreased in 2000, after a portion of the Hunter
property and all of the Brookfield property were sold during the last three
quarters of fiscal 2000.
The costs and expenses in the medical division for the three month and nine
month periods ended in 2000 was $552,000 and $1,802,000. The net increase of
$194,000 for the three month period was due to expenses of $228,000 that are
related to the three new subsidiaries that were formed in 2000 to manage the
operations of certain medical practices, offset by a decrease of $34,000 in
medical receivable expenses. The decrease in medical receivable expenses is
primarily due to a reduction of the amount of bad debt reserves for the three
month period ended in 2000.
The increase of $814,000 for the nine month period was due to expenses of
$739,000 that are related to the three new subsidiaries and a $75,000 increase
in medical receivable expenses. The $75,000 increase in medical receivable
expenses in the nine month period is attributable to additional expenses
incurred that were needed to properly service the current additions and
projected increases to the client base. These expenses included additional (i)
staff and related
20
<PAGE> 22
employment costs, in part due to reclassifying a portion of executive salaries
from corporate, part due to the hiring of additional employees and part due to
annual salary increases, (ii) occupancy and office costs, (iii) arbitration
costs in connection with the collection of claims receivable and (iv) closing
costs that are related to new clients. The infrastructure of the company as
established, can now service a greater number of clients than currently exists.
This is necessary to efficiently service expected new clients with properly
trained employees.
The decrease in corporate expenses of $19,000 and $4,000 in the three month and
nine month periods ended in 2000 is primarily due to reductions and
reallocations of professional fees to the medical division. The increase in
depreciation and amortization of $6,000 and $21,000 in the three month and nine
month periods ended in 2000 is attributable to additional depreciation as a
result of increased capital expenditures in the medical financing division.
Interest expense for the three months ended 2000 was $6,000, unchanged from
1999. Interest expense for the nine months ended 2000 was $19,000, a decrease of
$19,000 from $38,000 in 1999. The decrease was attributable to the debt that was
eliminated in 1999 when a portion of the proceeds from the sale of the Wendclark
subsidiary was used to repay amounts that had been borrowed to finance the
purchase of medical claims receivable, offset by acquisition, by capital lease,
of an MRI machine in the medical division.
Income from discontinued operations for the three month period, which included
the operations of the Wendcello subsidiary in 1999, decreased by $61,000 to
nothing in 2000, due to the sale of that subsidiary in the quarter ended August
31, 2000. The increase for the nine month period was $46,000, to $399,000 in
2000. The increases in 2000 were primarily due to the gain of $381,000 from the
sale of the Wendcello subsidiary in the nine month period. The increase in nine
month period, which included the gain on sale of Wendcello were offset by the
profits from that subsidiary that were included in the entire 1999 period.
For the reasons noted above, the Company's net loss was reduced by $51,000 for
the three months ended in 2000 to $194,000 as compared to a net loss of $245,000
in 1999. The loss for the nine month period in 2000 was $508,000, $293,000
greater than the loss of $215,000 in 1999.
LIQUIDITY AND CAPITAL RESOURCES
The Company's two continuing business activities and discontinued operations
during the nine months ended November 30, 2000 resulted in a decrease of cash in
the amount of $6,000. The Company expects the continued growth of its medical
division to increase based on its on-going negotiations with prospective new
clients, which are expected to be obtained in the next few months. These
prospective clients will result in an increase in the amount of cash needed to
purchase their medical insurance claims receivable. The funds for those needs
are expected to be provided from the balance of the $658,000 credit line.
Additional funds may be provided for from financing activities such as
additional asset-based borrowing facilities on the Company's mortgages and
accounts receivable and the sale of real estate assets.
The real estate division is not expected to be a significant user of cash flow
from operations, due to the elimination of carrying costs on the real estate
that was sold during the year ended
21
<PAGE> 23
February 29, 2000 and the nine months ended November 30, 2000. The Company's
real estate assets in Hunter, NY are owned free and clear of mortgages. Further
development of this property, at any significant cost, is expected to be funded
by the sale of property in Hunter or asset-based financing. The mortgage
receivable on the Goshen, NY property does not call for principal payments until
February 28, 2002, however, interest payments in the amount of $30,000 are due
annually. The annual payment that was due on February 29, 2000 has not been
paid, which resulted in the suspension of interest being accrued.
The Company believes that its present cash resources and the cash available from
financing activities will be sufficient on a short-term basis and over the next
12 months to fund continued expansion of its medical financing business, its
company-wide working capital needs and expected investments in property and
equipment. The Company intends to pace its growth in the medical financing
division to its capacity to provide the funds internally and from its financing
activities.
Cash used by operations during the nine months ended November 30, 2000 was
$466,000, as compared to $269,000 being used in the same period in 1999. The
$197,000 increase in the use of cash in 2000 was due to a net loss for the nine
months ended in 2000 of $508,000 (net of $381,000 gain on sale of subsidiary and
$208,000 provision for bad debts) as compared to a net loss of $215,000 (net of
$96,000 gain on sale of subsidiary and $22,000 provision for bad debts) in 1999,
a decrease in the sale of real estate, which resulted in a decrease in
collections of $212,000, offset by fluctuations in operating assets and
liabilities (including net assets of discontinued operations) primarily caused
by timing differences.
Cash provided by investing activities was $114,000 for the nine months ended in
2000 as compared with $1,372,000 being provided in 1999. The net decrease of
$1,258,000 was primarily due to the increase in medical insurance claims
receivable (net of amounts due to finance customers for payments of residual
collections) by $1,372,000 in 2000, compared to a $464,000 decrease in 1999. The
increase in 2000 was attributable to a greater amount of bills purchased,
beginning during the month of May from new clients. The use of cash by the
medical division was offset by an increase of $600,000 from discontinued
operations, resulting from the sale of the Wendcello subsidiary in June 2000.
Net cash provided by financing activities was $347,000 in 2000 as compared with
$854,000 being used in 1999. The $1,201,000 increase in 2000 was primarily due
to $275,000 of net borrowing in 2000 as compared to $854,000 of net debt
repayments in 1999. In addition, the company received $100,000 from a minority
interest in 2000. These proceeds were offset by the use of $28,000 to purchase
and acquire treasury stock in 2000.
EFFECTS OF NEW ACCOUNTING PRONOUNCEMENTS
ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
In June 1999, the Financial Accounting Standards Board issued Statement No. 137,
amending Statement No. 133, "Accounting for Derivative Instruments and Hedging
Activities", which extended the required date of adoption to the years beginning
after June 15, 2000. The Statement permits early adoption as of the beginning of
any fiscal
22
<PAGE> 24
quarter after its issuance. The Company expects to adopt the new Statement
effective March 1, 2001. The Company does not anticipate that the adoption of
this Statement will have any effect on its results of operations or financial
position.
REVENUE RECOGNITION IN FINANCIAL STATEMENTS
The Company expects to adopt Securities and Exchange Commission Staff Accounting
Bulletin 101 ("SAB 101"), Revenue Recognition in Financial Statements in the
quarter starting December 1, 2000. SAB 101 requires revenue to either be
realized or realizable and earned prior to recognition. This generally does not
occur until there is persuasive evidence of an arrangement, delivery has
occurred or services have been rendered, the price is fixed or determinable, and
collectibility is reasonably assured.The Company does not anticipate that the
adoption of SAB 101 will have any impact on the Company's current and prior
revenue recognition policies and its results of operations or financial
position.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company's market risk arises principally from the interest rate risk related
to its receivables. Interest rate risk is a consequence of having fixed interest
rate receivables in the Company's Real Estate and Medical Divisions. The Company
is exposed to interest rate risk arising from changes in the level of interest
rates.
PART II - OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
a) EXHIBITS.
None
b) REPORTS ON FORM 8K.
The Company filed a form 8K on October 19, 2000
23
<PAGE> 25
SIGNATURE
---------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
FRMO CORP.
By: /S/ VICTOR BRODSKY
---------------------------
Victor Brodsky
Vice President and
Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: January 12, 2001
24
